Sp1033
INTRODUCTION TO INTESTINAL ULTRASOUND: AN ADVANCED IBD FELLOWS HANDS-ON WORKSHOP
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
The Academy of Educators serves to support the careers of educators in GI/Hepatology. Our annual plenary session is an opportunity for those who identify as educators to build skills, strengthen our community, and celebrate the work being done by our junior colleagues. We will have two presentations by expert colleagues on teaching skills and teaching scholarship. Then we will hear from our four grant winners about their ongoing work. There will be opportunities to network with colleagues, learn about the Academy's ongoing projects, and engage with our working groups.
The Academy of Educators serves to support the careers of educators in GI/Hepatology. Our annual plenary session is an opportunity for those who identify as educators to build skills, strengthen our community, and celebrate the work being done by our junior colleagues. We will have two presentations by expert colleagues on teaching skills and teaching scholarship. Then we will hear from our four grant winners about their ongoing work. There will be opportunities to network with colleagues, learn about the Academy's ongoing projects, and engage with our working groups.
Speaker
Tracks
Related Products
INTRODUCTION
SOCIETY: AGA
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
ACTIVATING TRANSCRIPTION FACTOR 6 ACCELERATES MICROBIOTA-DEPENDENT RISK FOR COLITIS-ASSOCIATED CANCER IN INFLAMMATORY BOWEL DISEASES
BACKGROUND AND AIMS: Chemoresistance is a major cause of colorectal cancer (CRC) recurrence and death. The critical role of gut microbiome in the efficacy of CRC chemotherapy remains unclear…
